leisure time -WSS

leisure time

author：focus 2025-09-06 04:13:07 - browse：7791

Bill Cassidy speaks with his palm facing upward during a hearing on prescription drug costs — politics coverage from STAT — Sen. Bill Cassidy (R-La.) Kevin Dietsch/Getty Images

WASHINGTON — Republicans in Congress might try to use a technical maneuver to block the Biden administration from using so-called march-in rights to seize pharmaceutical patents and lower drug prices.

The Biden White House wants to ignore certain patents for inventions that were developed with government funding, at least in extenuating circumstances. Taxpayers have helped fund the research of a substantial number of drugs sold in the United States though the National Institutes of Health, so the proposal would let the government bring in generic drugmakers to make medicines even before their patents expire.

Until the Biden administration, the government refused to consider that an invention’s price could justify the “march in” maneuver. But the White House in December issued a draft framework for the NIH to more broadly use the power, including in cases where price is a concern.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Humana sues Biden admin over Medicare Advantage audit rule

focus

WSS

Addiction experts warn against a second 'war on drugs'

Medicaid rebukes states for mistakenly disenrolling children

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Crinetics acromegaly drug succeeds in late

AstraZeneca chief proposes a novel edit to the drug pricing bill

With measles on the rise, a personal story of a devastating disease

Wikipedia

leisure time

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Hepatitis C has a cure — but many Americans still lack access to it

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

New air purifier tech could be key to improving indoor air quality

Stem cell treatment guidelines are released by FDA

The high cost of giving birth even with insurance

Second House panel advances two

What does generative AI mean for health care? We asked experts

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

hotspot

Criminal prosecution for violating HIPAA: an emerging threat

NIH nominee Bertagnolli will get October confirmation hearing

Arc Institute generative AI designs new CRISPR systems

Data integrity in scientific journals requires "effort" by publishers, institutions

Solving academic medical centers' existential crisis

Data integrity in scientific journals requires "effort" by publishers, institutions

hotspot

focus

focus

entertainment